enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. FDA orders all Zantac heartburn products off store shelves

   www.aol.com/news/2020-04-01-fda-orders-all...

   ⚠️FDA requests market withdrawal of all remaining prescription and OTC ranitidine (Zantac) products on the U.S. market. This means that ranitidine will not be available for use in the U.S ...

3. Zantac settlements - Wikipedia

   en.wikipedia.org/wiki/Zantac_settlements

   Ranitidine, a heartburn medicine sold under the brand name Zantac among others, was pulled from shelves in 2019, [1] following disclosure [2] of potential carcinogenic effects, [3] [4] which its manufacturers were accused of "engaging in a decades-long scheme to conceal." [5]

4. Ranitidine - Wikipedia

   en.wikipedia.org/wiki/Ranitidine

   Ranitidine is an H 2 histamine receptor antagonist that works by blocking histamine, thus decreasing the amount of acid released by cells of the stomach. [12] Ranitidine was discovered in England in 1976 and came into commercial use in 1981. [26] It is on the World Health Organization's List of Essential Medicines.

5. List of withdrawn drugs - Wikipedia

   en.wikipedia.org/wiki/List_of_withdrawn_drugs

   This list is not limited to drugs that were ever approved by the FDA. Some of them (lumiracoxib, rimonabant, tolrestat, ximelagatran and ximelidine, for example) were approved to be marketed in Europe but had not yet been approved for marketing in the US, when side effects became clear and their developers pulled them from the market.

6. Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

   www.aol.com/news/sanofi-settle-4-000-zantac...

   NEW YORK (Reuters) -Sanofi has reached an agreement in principle to settle 4,000 U.S. lawsuits linking the discontinued heartburn drug Zantac to cancer, the company said on Wednesday. Sanofi did ...

7. Tariff threats, drug pricing will be 2 key pharma issues ...

   www.aol.com/finance/tariff-threats-drug-pricing...

   In a note during third quarter earnings back in October, Mizuho noted that J&J, for example, is the largest player in China's medical technology market and gets 5% of its revenue from there.

8. Zantac - Wikipedia

   en.wikipedia.org/wiki/Zantac

   Ranitidine, prior to its 2020 withdrawal from the market; Famotidine, following the withdrawal of ranitidine This page was last edited on 20 ...

9. Some Federal Health Agencies Resume Public Communications ...

   www.aol.com/lifestyle/health-agency-reports-cdc...

   Some federal health websites and reports have reappeared after the Trump administration ordered a pause on public communications from agencies like the CDC, FDA, and NIH in January.